Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Sees Large Decr

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 303,000 shares, a decrease of 17.6% from the November 30th total of 367,800 shares. Based on an average daily volume of 2,400,000 shares, […]

Related Keywords

, Dimensional Fund Advisors , Processa Pharmaceuticals Inc , Maxim Group , Sigma Securities , News Ratings For Processa Pharmaceuticals Daily , Nasdaq , Raymond James Financial Services Advisors Inc , Institutional Investors Weigh In On Processa Pharmaceuticals , Processa Pharmaceuticals Stock Performance , Citadel Advisors , Processa Pharmaceuticals , Walleye Capital , Get Free Report , James Financial Services Advisors , Processa Pharmaceuticals Daily , Nasdaq Pcsa , Hpcsa , Medical , Stocks , Options , Put , Call ,